Menopause resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0"; | {| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0" ; | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align=center| {{fontcolor|#2B3B44|Menopause Resident Survival Guide Microchapters}} | ! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align="center" |{{fontcolor|#2B3B44|Menopause Resident Survival Guide Microchapters}} | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Overview|Overview]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Overview|Overview]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Causes|Causes]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Causes|Causes]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Diagnosis|Diagnosis]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Diagnosis|Diagnosis]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Treatment|Treatment]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Treatment|Treatment]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Do's|Do's]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Do's|Do's]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Menopause resident survival guide#Don'ts|Don'ts]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align="left" |[[Menopause resident survival guide#Don'ts|Don'ts]] | ||
|} | |} | ||
{{WikiDoc CMG}}; {{AE}} {{Ayeesha}} | {{WikiDoc CMG}}; {{AE}} {{Ayeesha}} | ||
Line 24: | Line 24: | ||
==Causes== | ==Causes== | ||
===Common Causes=== | ===Common Causes=== | ||
Commn causes of menopause include:<ref name="pmid26316241">{{cite journal| author=Rodriguez M, Shoupe D| title=Surgical Menopause. | journal=Endocrinol Metab Clin North Am | year= 2015 | volume= 44 | issue= 3 | pages= 531-42 | pmid=26316241 | doi=10.1016/j.ecl.2015.05.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26316241 }} </ref> <ref name="pmid31416275">{{cite journal| author=Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R| title=Surgically Induced Menopause-A Practical Review of Literature. | journal=Medicina (Kaunas) | year= 2019 | volume= 55 | issue= 8 | pages= | pmid=31416275 | doi=10.3390/medicina55080482 | pmc=6722518 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31416275 }} </ref> <ref name="pmid29225794">{{cite journal| author=Torrealday S, Kodaman P, Pal L| title=Premature Ovarian Insufficiency - an update on recent advances in understanding and management. | journal=F1000Res | year= 2017 | volume= 6 | issue= | pages= 2069 | pmid=29225794 | doi=10.12688/f1000research.11948.1 | pmc=5710309 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29225794 }} </ref> <ref name="pmid26485568">{{cite journal| author=Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM | display-authors=etal| title=Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. | journal=PLoS One | year= 2015 | volume= 10 | issue= 10 | pages= e0140842 | pmid=26485568 | doi=10.1371/journal.pone.0140842 | pmc=4613138 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26485568 }} </ref> | Commn causes of menopause include: <ref name="pmid26316241">{{cite journal| author=Rodriguez M, Shoupe D| title=Surgical Menopause. | journal=Endocrinol Metab Clin North Am | year= 2015 | volume= 44 | issue= 3 | pages= 531-42 | pmid=26316241 | doi=10.1016/j.ecl.2015.05.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26316241 }} </ref> <ref name="pmid31416275">{{cite journal| author=Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R| title=Surgically Induced Menopause-A Practical Review of Literature. | journal=Medicina (Kaunas) | year= 2019 | volume= 55 | issue= 8 | pages= | pmid=31416275 | doi=10.3390/medicina55080482 | pmc=6722518 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31416275 }} </ref> <ref name="pmid29225794">{{cite journal| author=Torrealday S, Kodaman P, Pal L| title=Premature Ovarian Insufficiency - an update on recent advances in understanding and management. | journal=F1000Res | year= 2017 | volume= 6 | issue= | pages= 2069 | pmid=29225794 | doi=10.12688/f1000research.11948.1 | pmc=5710309 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29225794 }} </ref> <ref name="pmid26485568">{{cite journal| author=Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM | display-authors=etal| title=Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. | journal=PLoS One | year= 2015 | volume= 10 | issue= 10 | pages= e0140842 | pmid=26485568 | doi=10.1371/journal.pone.0140842 | pmc=4613138 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26485568 }} </ref> | ||
* Natural [[menopause]] | |||
* [[Premature ovarian failure]] or Early [[menopause]] | *Natural [[menopause]] | ||
* Surgical [[menopause]] | *[[Premature ovarian failure]] or Early [[menopause]] | ||
* [[Chemotherapy]] and [[radiation]] induced [[menopause]] | *Surgical [[menopause]] | ||
*[[Chemotherapy]] and [[radiation]] induced [[menopause]] | |||
==Diagnosis== | ==Diagnosis== | ||
Shown below is an algorithm summarizing the diagnosis of [[menopause]]. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> | Shown below is an algorithm summarizing the diagnosis of [[menopause]]. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref><ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref><ref>https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause</ref> | ||
<ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref> <ref>https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause</ref> | |||
{{familytree/start |summary= Menopause diagnosis Algorithm.}} | {{familytree/start |summary= Menopause diagnosis Algorithm.}} | ||
Line 56: | Line 56: | ||
{{familytree | | | | | | | | | | | | | | B01 | | | | | | | | | | |B01=[[Menopausal]] symptoms}} | {{familytree | | | | | | | | | | | | | | B01 | | | | | | | | | | |B01=[[Menopausal]] symptoms}} | ||
{{familytree | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | }} | {{familytree | | |,|-|-|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|-|-|-|.| | }} | ||
{{familytree | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 |C01=[[Genitourinary]]<br>syndrome of [[menopause]] <br> (vaginal dryness, itching,<br> dyspareunia, urinary incontinence)|C02= [[Vasomotor]] symptoms <br> (hot flashes, night sweats)|C03= Sleep problems}} | {{familytree | | C01 | | | | | | | | | | C02 | | | | | | | | | C03 |C01=[[Genitourinary]]<br>syndrome of [[menopause]] <br> ([[vaginal]] dryness, [[Vaginal itching|itching]],<br> [[dyspareunia]], [[urinary incontinence]])|C02= [[Vasomotor]] symptoms <br> (hot flashes, night sweats)|C03= Sleep problems}} | ||
{{familytree | | |!| | | | | | | | | | | |!| | | | | | | | | | |!| |}} | {{familytree | | |!| | | | | | | | | | | |!| | | | | | | | | | |!| |}} | ||
{{familytree | | D01 | | | | | | | | | | D02 | | | | | | | | | D03 |D01= Water based lubricants <br> Ospemifene <br> Vaginal oestrogen|D02= Based on patient preference |D03= Regular exercise | {{familytree | | D01 | | | | | | | | | | D02 | | | | | | | | | D03 |D01= Water based lubricants <br> Ospemifene <br> Vaginal oestrogen|D02= Based on patient preference |D03= Regular exercise <br> Sleep hygiene <br> Avoid alcohol and caffeine}} | ||
{{familytree | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | | |D05=D05}} | {{familytree | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | | |D05=D05}} | ||
{{familytree | | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | |E01=Life style<br> modification |E02=Medical therapy|}} | {{familytree | | | | | | | | | E01 | | | | | | | | E02 | | | | | | | | |E01=Life style<br> modification |E02=Medical therapy|}} | ||
Line 72: | Line 72: | ||
==Do's== | ==Do's== | ||
*In women with [[moderate]] risk of [[cardiovascular disease]] requiring treatment for [[vasomotor]] symptoms of [[menopause]], use [[transdermal]] [[estradiol]] alone or in combination with micronised [[progesterone]] in women with [[uterus]] instead of oral oestrogen preparations. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> | *In women with [[moderate]] risk of [[cardiovascular disease]] requiring treatment for [[vasomotor]] symptoms of [[menopause]], use [[transdermal]] [[estradiol]] alone or in combination with micronised [[progesterone]] in women with [[uterus]] instead of oral oestrogen preparations. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> | ||
<ref>https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments</ref> | <ref>https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments</ref> | ||
*In women on [[hormone replacement therapy]], use the lowest possible dose for the shortest duration(3-5 years). | |||
*In women on [[hormone replacement therapy]], use the lowest possible dose for the shortest duration(3-5 years). | |||
*In women on [[hormone replacement therapy]] with unscheduled [[bleeding]], evaluate for [[endometrial]] [[hyperplasia]] and [[endometrial]] [[cancer]]. | *In women on [[hormone replacement therapy]] with unscheduled [[bleeding]], evaluate for [[endometrial]] [[hyperplasia]] and [[endometrial]] [[cancer]]. | ||
*In women with [[primary ovarian insufficiency]] and [[surgical menopause]], [[hormonal replacement therapy]] to be given until anticipated age of [[menopause]]. | *In women with [[primary ovarian insufficiency]] and [[surgical menopause]], [[hormonal replacement therapy]] to be given until anticipated age of [[menopause]]. | ||
Line 81: | Line 84: | ||
==Don'ts== | ==Don'ts== | ||
* Do not use measurements of [[anti müllerian]] [[hormone]], [[inhibin B]], [[estradiol]], [[FSH]], [[LH]], [[testosterone]] in the diagnosis of menopause in women of age ≥45 years. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> <ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref> | |||
* Do not use [[FSH]] levels in diagnosing [[menopause]] in women <45 years of age who are on oral contraceptives. | *Do not use measurements of [[anti müllerian]] [[hormone]], [[inhibin B]], [[estradiol]], [[FSH]], [[LH]], [[testosterone]] in the diagnosis of menopause in women of age ≥45 years. <ref name="StuenkelDavis2015">{{cite journal|last1=Stuenkel|first1=Cynthia A.|last2=Davis|first2=Susan R.|last3=Gompel|first3=Anne|last4=Lumsden|first4=Mary Ann|last5=Murad|first5=M. Hassan|last6=Pinkerton|first6=JoAnn V.|last7=Santen|first7=Richard J.|title=Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline|journal=The Journal of Clinical Endocrinology & Metabolism|volume=100|issue=11|year=2015|pages=3975–4011|issn=0021-972X|doi=10.1210/jc.2015-2236}}</ref> <ref>https://www.nice.org.uk/guidance/ng23/chapter/Recommendations</ref> | ||
* Do not use [[hormonal]] replacement therapy in women with high risk for [[cardiovascular]] disease, [[venous thromboembolism]], [[breast cancer]]. | *Do not use [[FSH]] levels in diagnosing [[menopause]] in women <45 years of age who are on oral contraceptives. | ||
* Do not recommend use of [[complimentary medicine]] treatment options like [[black cohash]], [[omega-3 fatty acids]], [[red clover]], [[vitamin E]] due to lack of sufficient data proving its efficacy. | *Do not use [[hormonal]] replacement therapy in women with high risk for [[cardiovascular]] disease, [[venous thromboembolism]], [[breast cancer]]. | ||
*Do not recommend use of [[complimentary medicine]] treatment options like [[black cohash]], [[omega-3 fatty acids]], [[red clover]], [[vitamin E]] due to lack of sufficient data proving its efficacy. | |||
*Do not use [[ospemifene]] for [[vaginal]] dryness in women with history of [[breast cancer]]. | *Do not use [[ospemifene]] for [[vaginal]] dryness in women with history of [[breast cancer]]. | ||
Line 91: | Line 95: | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category:needs review]] |
Latest revision as of 23:22, 30 July 2021
Menopause Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayeesha Kattubadi, M.B.B.S[2]
Synonyms and keywords: Perimenopause approach, Climacteric workup, Approach to menopause, Menopause workup, Menopause management
Overview
Menopause is a clinical state indicating the permanent cessation of ovarian function. Perimenopause refers to the period of transitioning before menopause characterised by irregular menstrual cycles. The diagnosis of menopause is made retrospectively based on the absence of menstrual cycles for 12 months. The average age of menopause is 51 years. Women can have symptoms of hot flashes, night sweats, sleep disturbance, mood changes, decreased libido, vaginal dryness, dyspareunia, etc. Women with intolerable symptoms can be treated with hormonal and non hormonal therapy. Conditions where menopause can occur early are primary ovarian insufficiency, bilateral oophorectomy, chemotherapy and radiation induced.
Causes
Common Causes
Commn causes of menopause include: [1] [2] [3] [4]
- Natural menopause
- Premature ovarian failure or Early menopause
- Surgical menopause
- Chemotherapy and radiation induced menopause
Diagnosis
Shown below is an algorithm summarizing the diagnosis of menopause. [5][6][7]
Presence of Menopausal Symptoms + irregular/absent menstrual periods | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Age | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
≥45 years | 40-45 years | ≤40 years | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Uterus | Rule out other causes like pregnancy, hyperthyroidism, prolactinoma | Rule out medical and surgical causes of amenorrhea/oligomenorrhe | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Absent | Present | Normal | Abnormal | Measure FSH and Estradiol two samples 4-6 weeks apart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Menopause diagnosed based on symptoms | Irregular periods+ menopausal symptoms | Amenorrhea>12 months ± menopausal symptoms | Amenorrhea > 12 months | Menopause ruled out | FSH elevated Estradiol depressed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perimenopause | Menopause | Early menopause | Premature ovarian failure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of menopause. [5] [8] [9]
Menopausal symptoms | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genitourinary syndrome of menopause (vaginal dryness, itching, dyspareunia, urinary incontinence) | Vasomotor symptoms (hot flashes, night sweats) | Sleep problems | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Water based lubricants Ospemifene Vaginal oestrogen | Based on patient preference | Regular exercise Sleep hygiene Avoid alcohol and caffeine | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Life style modification | Medical therapy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Avoid smoking, caffeine, alcohol -Use of fan, cool bedroom, cool shower -Relaxation exercises | Hormonal replacement therapy | Non-hormonal therapy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Post hysterectomy status | When hormonal use is contraindicated (History of breast cancer, Venous thromboembolism, Undiagnosed vaginal bleeding, etc. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hysterectomised | Uterus in-situ | Paroxetine(SSRI) Clonidine Gabapentin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oestrogen alone | Oestrogen+Progesterone | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- In women with moderate risk of cardiovascular disease requiring treatment for vasomotor symptoms of menopause, use transdermal estradiol alone or in combination with micronised progesterone in women with uterus instead of oral oestrogen preparations. [5]
- In women on hormone replacement therapy, use the lowest possible dose for the shortest duration(3-5 years).
- In women on hormone replacement therapy with unscheduled bleeding, evaluate for endometrial hyperplasia and endometrial cancer.
- In women with primary ovarian insufficiency and surgical menopause, hormonal replacement therapy to be given until anticipated age of menopause.
- Counsel patients regarding continued symptoms after discontinuing hormone replacement therapy.
- To maintain bone health recommended weight-bearing exercises, calcium and vitamin D supplements.
Don'ts
- Do not use measurements of anti müllerian hormone, inhibin B, estradiol, FSH, LH, testosterone in the diagnosis of menopause in women of age ≥45 years. [5] [11]
- Do not use FSH levels in diagnosing menopause in women <45 years of age who are on oral contraceptives.
- Do not use hormonal replacement therapy in women with high risk for cardiovascular disease, venous thromboembolism, breast cancer.
- Do not recommend use of complimentary medicine treatment options like black cohash, omega-3 fatty acids, red clover, vitamin E due to lack of sufficient data proving its efficacy.
- Do not use ospemifene for vaginal dryness in women with history of breast cancer.
References
- ↑ Rodriguez M, Shoupe D (2015). "Surgical Menopause". Endocrinol Metab Clin North Am. 44 (3): 531–42. doi:10.1016/j.ecl.2015.05.003. PMID 26316241.
- ↑ Secoșan C, Balint O, Pirtea L, Grigoraș D, Bălulescu L, Ilina R (2019). "Surgically Induced Menopause-A Practical Review of Literature". Medicina (Kaunas). 55 (8). doi:10.3390/medicina55080482. PMC 6722518 Check
|pmc=
value (help). PMID 31416275. - ↑ Torrealday S, Kodaman P, Pal L (2017). "Premature Ovarian Insufficiency - an update on recent advances in understanding and management". F1000Res. 6: 2069. doi:10.12688/f1000research.11948.1. PMC 5710309. PMID 29225794.
- ↑ Liem GS, Mo FK, Pang E, Suen JJ, Tang NL, Lee KM; et al. (2015). "Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles". PLoS One. 10 (10): e0140842. doi:10.1371/journal.pone.0140842. PMC 4613138. PMID 26485568.
- ↑ 5.0 5.1 5.2 5.3 Stuenkel, Cynthia A.; Davis, Susan R.; Gompel, Anne; Lumsden, Mary Ann; Murad, M. Hassan; Pinkerton, JoAnn V.; Santen, Richard J. (2015). "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism. 100 (11): 3975–4011. doi:10.1210/jc.2015-2236. ISSN 0021-972X.
- ↑ https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
- ↑ https://www.menopause.org.au/hp/gp-hp-resources/300-diagnosing-menopause
- ↑ "ACOG Releases Clinical Guidelines on Management of Menopausal Symptoms - Practice Guidelines - American Family Physician".
- ↑ "What are the treatments for other symptoms of menopause? | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development".
- ↑ https://www.nichd.nih.gov/health/topics/menopause/conditioninfo/treatments
- ↑ https://www.nice.org.uk/guidance/ng23/chapter/Recommendations